fda warning letter semaglutide october 2025 Democratic lawmakers are pressing the Trump administration to disclose who received special access to Eli Lilly's investigational obesity drug retatrutide. Sen. Maggie Hassan (D-N.H.) sent a to HHS Secretary Robert F FDA warns Ozempic and Wegovy

Introduction In our ongoing pursuit of health and well-being, many individuals encounter a frustrating hurdle: a weight loss plateau that seems insurmountable despite dedicated efforts

For patients unfamiliar with self-injection, this can initially feel daunting, but the technique is straightforward and is routinely taught by healthcare professionals

Enter the GLOW Peptide Therapy, a sophisticated protocol combining three powerful regenerative peptides: BPC-157, TB-500, and GHK-Cu

Foods to Avoid The key to lowering heart disease risk factors, including high cholesterol, is reducing inflammation

Foundayo enables significant weight loss, with participants losing an average of 12.4% body weight in trials